A groundbreaking lung cancer screening project co-led by the University of Kentucky Markey Cancer Center and the University of Colorado (CU) Cancer Center is set to expand its reach, thanks to a $6.8 million grant from the Bristol Myers Squibb Foundation, an independent charitable organization.
QUILS™ (Quality Implementation of Lung Cancer Screening), led by UK Markey Cancer Center researchers Jennifer Redmond Knight, Dr.P.H., and Timothy Mullett, M.D., and Jamie Studts, Ph.D., from the University of Colorado Anschutz Medical Campus (CU-AMC), has helped to transform Kentucky’s approach to lung cancer screening over the past decade.
Despite grappling with the nation’s highest lung cancer incidence and mortality rates, Kentucky now has the second-highest rate of lung cancer screening in the U.S. The turnaround is due in part to QUILS™ System, which has helped Kentucky’s health care providers improve their lung cancer screening processes.
